The institute will concentrate on developing new medicines to treat cancer, heart disease and strokes, malaria and TB. It will bring together researchers in chemistry, biology and pharmacy.
Strathclyde University invested £28m in the drug research institute and had support from the European Regional Development Fund and the Scottish Funding Council. A further £8m was also raised through fundraising with surgeon and TV presenter Professor Lord Winston.
Strathclyde University is renowned for their expertise and research capabilities within the chemical, biological and pharmaceutical sciences. University Principal, Jim McDonald, stated,
“The investment in our advanced facilities will help our scientists find new and better treatments and reflects Strathclyde’s commitment to finding solutions to the global challenges of the 21st century.
“By bringing together talented multidisciplinary researchers with colleagues in the NHS, business and industry, we are in the ideal position to accelerate the pace of research and translate it into products that benefit patients.”